At the heart of this resurgence lies the remarkable speed at which the Wegovy pill has penetrated the market. The latest surge in demand for Wegovy has delivered a decisive boost to Novo Nordisk,…
Pfizer executives are confident about the monthly dosing approach of Metsera’s drug, as the drug remains in the patient’s body long enough without worsening side effects between doses. Pfizer announced…
The partnership between GSK and Hengrui is part of a growing trend of license deals signed between Chinese and global multinational corporations, whose inventions are helping transform global treatment pipelines.…